the AHA Get With the Guidelines Program. Dr. Lichtman received her Ph.D. in epidemiology from Yale University.
Martha Nolan, J.D., is vice president of public policy for the Society for Women’s Health Research. She is responsible for the development and implementation of the society’s government-relations and public-policy programs. She also provides advice and counsel to the society president on public-policy goals and strategies. Dr. Nolan joined the society staff in September 2003 and has over 17 years of experience in working for the health-insurance industry. Her most recent experience was as assistant vice president for federal affairs at MetLife. Before joining MetLife, she was counsel for state affairs for United Health Group, where she oversaw lobbying, coordinated advocacy, and managed state legislative and regulatory issues for over half the country. She has also worked for CIGNA and the Health Insurance Association of America. A lawyer by profession, Dr. Nolan earned her J.D. at Suffolk University Law School. She received a bachelor’s degree in American history from Harvard University.
Ameeta Parekh, Ph.D., is the director of research and development in the Office of Women’s Health (OWH) of the Food and Drug Administration (FDA). She leads the science program in OWH through collaborations and partnerships with other scientists in the FDA centers and with external leaders advancing women’s health. As the OWH R&D director, Dr. Parekh represents FDA and OWH in national and international organizations and meetings to advance the scientific understanding of sex differences and provides FDA regulatory updates on the participation of women in clinical trials and the regulations, policies, and review practices around this topic. Dr. Parekh’s background is in clinical pharmacology, pharmacokinetics, pharmacodynamics, and biopharmaceutics, and she has extensive regulatory experience at FDA, where she has worked for 25 years. Before joining OWH, she was a clinical-pharmacology lead in drug development with the Center for Drug Evaluation and Research in cardiovascular, gastrointestinal, reproductive, and urologic drugs. She is the FDA regulatory expert scientist for food effects and bioavailability of drugs. She has published extensively in peer-reviewed journals and book chapters and presented widely on women's health, drug development, clinical pharmacology, subgroup populations in drug development, and the drug-approval process.